These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3402591)

  • 1. Prognostic factors in Hodgkin's disease stage III with special reference to tumour burden.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Jul; 41(1):80-7. PubMed ID: 3402591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in Hodgkin's disease stage IV.
    Specht L; Nissen NI
    Eur J Haematol; 1988 Oct; 41(4):359-67. PubMed ID: 3197822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease and age.
    Specht L; Nissen NI
    Eur J Haematol; 1989 Aug; 43(2):127-35. PubMed ID: 2792320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour burden in early stage Hodgkin's disease: the single most important prognostic factor for outcome after radiotherapy.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Br J Cancer; 1987 May; 55(5):535-9. PubMed ID: 3300762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
    Specht L; Nordentoft AM; Cold S; Clausen NT; Nissen NI
    Cancer; 1988 Apr; 61(8):1719-27. PubMed ID: 3349432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
    Specht L; Nissen NI
    Scand J Haematol; 1986 Apr; 36(4):367-75. PubMed ID: 3754976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour burden as the main indicator of prognosis in Hodgkin's disease.
    Specht L
    Eur J Cancer; 1992; 28A(12):1982-5. PubMed ID: 1419295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for early infradiaphragmatic Hodgkin's disease: the Australasian experience.
    Barton M; Boyages J; Crennan E; Davis S; Fisher RJ; Hook C; Johnson N; Joseph D; Khoo V; Liew KH; Morgan G; O'Brien P; Pendlebury S; Pratt G; Quong G; Roos DE; Thornton D; Trotter G; Walker Q; Wallington M
    Radiother Oncol; 1996 Apr; 39(1):1-7. PubMed ID: 8735487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination.
    Specht L; Nissen NI
    Eur J Haematol; 1988 May; 40(5):396-402. PubMed ID: 3378595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for positive surgical staging in patients with Hodgkin's disease.
    Mauch P; Larson D; Osteen R; Silver B; Yeap B; Canellos G; Weinstein H; Rosenthal D; Pinkus G; Jochelson M
    J Clin Oncol; 1990 Feb; 8(2):257-65. PubMed ID: 2299369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage I and II subdiaphragmatic Hodgkin's disease.
    Mai DH; Peschel RE; Portlock C; Knowlton A; Farber L
    Cancer; 1991 Oct; 68(7):1476-81. PubMed ID: 1893346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.
    Vlachaki MT; Hagemeister FB; Fuller LM; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):593-9. PubMed ID: 9231684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
    Specht L; Nissen NI; Walbom-Jørgensen S
    Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic substages of stage III-A Hodgkin's disease. A collaborative study.
    Stein RS; Golomb HM; Diggs CH; Mauch P; Hellman S; Wiernik PH; Ultmann JE; Rosenthal DS
    Ann Intern Med; 1980 Feb; 92(2 Pt 1):159-65. PubMed ID: 7352720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.